VIM-1-producing Pseudomonas mosselii isolates in Italy, predating known VIM-producing index strains

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2216-2217

  Giani, Tommaso ^a   Marchese, Anna ^b   Coppo, Erika ^b   Kroumova, Vesselina ^c   Rossolini, Gian Maria ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c University Hospital Maggiore della Carita   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG; VIM 1 ENZYME;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; ENZYME ACTIVITY; GENE SEQUENCE; ITALY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS MOSSELII;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84858626146     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06005-11     Document Type: Letter

References (12)

1. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-β- lactamases: a last frontier for β-lactams? Lancet Infect. Dis. 11:381-393.
3. Dabboussi F, et al. 2002. Pseudomonas mosselii sp. nov., a novel species isolated from clinical specimens. Int. J. Syst. Evol. Microbiol. 52:363-376. (Pubitemid 34266067)
4. D'Andrea M, et al. 2011. Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. J. Clin. Microbiol. 49:2755-2758.
5. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
6. Mclellan E, Partridge D. 2009. Prosthetic valve endocarditis caused by Pseudomonas mosselii. J. Med. Microbiol. 58:144-145.
7. Mulet M, Lalucat JJ, García-Valdés E. 2010. DNA sequence-based analysis of the Pseudomonas species. Environ. Microbiol. 12:1512-1530.
8. Naik P, Raman G, Narayanan K, Sakthivel N. 2008. Assessment of genetic and functional diversity of phosphate solubilizing fluorescent pseudomonads isolated from rhizospheric soil. BMC Microbiol. 8:230.
9. Naik P, Sahoo N, Goswami D, Ayyadurai N, Sakthivel N. 2008. Genetic and functional diversity among fluorescent pseudomonads isolated from the rhizosphere of banana. Microb. Ecol. 56:492-504.
10. Poirel L, et al. 2000. Characterization of VIM-2, a carbapenem- hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897. (Pubitemid 30165266)
11. VIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45:1249-1253.
12. Riccio M, et al. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110. (Pubitemid 40065779)